Pricing Log in Create free account

Aurora Cannabis Inc. (ACB) vs Anika Therapeutics Inc. (ANIK)

Aurora Cannabis Inc. and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $341.2M against $258.7M — 1.3× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −18.2%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −38.1%) and the higher return on invested capital (−3.24% vs −5.58%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Aurora Cannabis Inc. on 6.

Valuation

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 2.13 2.08
P/B 0.84 1.88 1.79
Price to free cash flow n/m 458.01 16.29
EV/EBITDA n/m 476.54 12.22
EV/Sales 1.28 2.02 2.87
Earnings yield (27.12%) (1.35%) (15.94%)
Free cash flow yield (11.26%) 0.22% 0.00%

Profitability

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 62.16% 53.51%
Operating margin (12.13%) (4.24%) 0.00%
Net margin (38.12%) (3.14%) (2.45%)
Free cash flow margin (17.19%) 0.47% 0.00%
Return on equity (19.85%) (2.66%) (0.80%)
Return on assets (15.19%) (2.04%) (1.67%)
Return on invested capital (5.58%) (3.24%) 0.00%

Growth

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 5.33% 5.22%
EPS growth (last fiscal year) (5,266.67%) 80.16% 42.91%
Revenue growth, 5-year CAGR 3.92% (2.86%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.00 0.04
Current ratio 5.36 4.48 2.41
Net debt to EBITDA 5.11 10.80 1.01

Dividend

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB ANIK Drug Manufacturers Specialty & Generic median
Market cap 341.19m 258.69m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack